Balance Sheet
Cash Flow Statement
Capital ExpendituresCapital ExpendituresCash from Financing ActivitiesCash from Financing ActivitiesCash from Investing ActivitiesCash from Investing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in Acquisitions & DivestmentsChange in CashDepreciation & Amortization (CF)Depreciation & Amortization (CF)Depreciation and DepletionDepreciation and DepletionFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

TScan Therapeutics (TCRX) Change in Account Payables (2020 - 2025)

TScan Therapeutics (TCRX) has disclosed Change in Account Payables for 6 consecutive years, with -$5.1 million as the latest value for Q4 2025.

  • Quarterly Change in Account Payables fell 615.46% to -$5.1 million in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$3.0 million through Dec 2025, down 251.0% year-over-year, with the annual reading at -$3.0 million for FY2025, 251.0% down from the prior year.
  • Change in Account Payables for Q4 2025 was -$5.1 million at TScan Therapeutics, down from $1.9 million in the prior quarter.
  • The five-year high for Change in Account Payables was $1.9 million in Q3 2025, with the low at -$5.1 million in Q4 2025.
  • Average Change in Account Payables over 5 years is -$26550.0, with a median of $402000.0 recorded in 2022.
  • The sharpest move saw Change in Account Payables crashed 4496.43% in 2021, then surged 475.46% in 2024.
  • Over 5 years, Change in Account Payables stood at -$2.5 million in 2021, then skyrocketed by 116.82% to $414000.0 in 2022, then tumbled by 254.83% to -$641000.0 in 2023, then skyrocketed by 253.35% to $983000.0 in 2024, then plummeted by 615.46% to -$5.1 million in 2025.
  • According to Business Quant data, Change in Account Payables over the past three periods came in at -$5.1 million, $1.9 million, and -$435000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.